InvestLog
GNLX Genelux Corporation logo

GNLX Genelux Corporation

Healthcare
$3.01+3.08%ClosedMarket Cap: $113.2M

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

0

Dispositions

4

Buy/Sell Ratio

0.00

Net Shares

-4,278

Shares Acquired

0

Shares Disposed

4,278

Total Bought ($)

$0.00

Total Sold ($)

$4.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Tue May 12Zindrick Thomasofficer: President and CEOSell2,798$2.94532,051
Tue May 12Yu Yongofficer: Chief Scientific OfficerSell605$2.97149,706
Tue May 12Smalling Ralphofficer: Head of RegulatorySell270$2.9867,803
Tue May 12Cappello Josephofficer: Chief Technical OfficerSell605$2.97154,549
Thu Mar 26Zindrick Thomasofficer: President and CEOSell3,582$2.42534,849
Thu Mar 26Yu Yongofficer: SVP, Clinical DevelopmentSell906$2.42144,938
Thu Mar 26Smalling Ralphofficer: Head of RegulatorySell345$2.4268,313
Thu Mar 26Smalling Ralphofficer: Head of RegulatorySell240$2.5168,073
Thu Mar 26Cappello Josephofficer: Chief Technical OfficerSell906$2.42155,154
Tue Mar 03Thomas JohndirectorSell10,000$2.90482,784
Wed Jan 07Litten Jasonofficer: Chief Medical OfficerSell275,000$4.55275,000
Wed Jan 07Litten JasonofficerSell0$0.000
Thu Dec 11Zindrick Thomasofficer: President and CEOSell12,673$3.33542,940
Thu Dec 11Zindrick Thomasofficer: President and CEOSell4,509$5.37538,431
Thu Dec 11Yu Yongofficer: SVP, Clinical DevelopmentSell3,219$3.36146,817